Ophthotech Corp (OPHT) Announces Gene Therapy Agreements with University of Florida and Penn

June 7, 2018 7:27 AM
Ophthotech Corporation (NASDAQ: OPHT) announced today that it has entered into an exclusive global license agreement with the University of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles